Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial
Compound improves survival in aggressive acute myeloid leukaemia with manageable added toxicity in phase III trial
ecancermedicalscience editor's choice for November 2014
Male cancer patients less likely to seek counselling but respond very well when they do
Choir-singing improves cancer patients' mental health
Red wine and other food-derived agents to prevent cancer
Meaning-centred psychotherapy for cancer patients
Linguistic considerations in cancer-related dialogue and their psychosocial impacts
Uganda and the need for pain control in palliative care
Finding biomarkers to assess frailty in cancer patients
CLL in the elderly: Expert panel discussion
Research shows chemotherapy has no negative effects on babies in utero
Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer